Salem Radio Network News Monday, September 27, 2021

Health

Emergent to make Providence Therapeutics’ potential COVID-19 vaccine

(Reuters) – Emergent BioSolutions Inc signed a five-year agreement with Providence Therapeutics to develop and manufacture its COVID-19 vaccine candidate, the companies said on Tuesday.

The agreement signed between Emergent and Providence Therapeutics is valued at about $90 million.

(Reporting by Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli)

Previous
Next

Editorial Cartoons

View More »

Gary Varvel
Tue, Sep 21, 2021

X CLOSE